A toxicity study of low-dose rate half-body irradiation and chemotherapy in dogs with lymphoma

Veterinary and Comparative Oncology

Volumn 6, Issue 4, 2008, Pages 257-267

  Lurie, D M ^a   Kent, M S ^b   Fry, M M ^c   Theon A P ^b  

^a University of Florida   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Bone marrow; Gastrointestinal; Toxicity; Wide field irradiation

Indexed keywords

CANIS FAMILIARIS;

ANTINEOPLASTIC AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; DOSE RESPONSE; FEMALE; LYMPHOMA; MALE; RADIATION INJURY; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HEMIBODY IRRADIATION; LYMPHOMA; MALE; RADIATION INJURIES;

EID: 63849279680     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2008.00164.x     Document Type: Article

References (33)

1. Zemann BI, Moore AS, Rand WM, Mason G, Ruslander DM, Frimberger AE, Wood CA, L'Heureux DA, Gliatto J and Cotter SM. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma. Journal of Veterinary Internal Medicine 1998; 12: 465-470.
2. Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich R. Overview. In: Principles and Practice of Radiation Oncology. Philadelphia, PA, Lippincott-Raven, 1997: 1-78.
3. Schlembach PJ, Wilder RB, Tucker SL, Ha CS, Rodriguez MA, Hess MA, Cabanillas FF and Cox JD. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas. International Journal of Radiation Oncology, Biology and Physics 2000; 48: 1107-1110.
4. Wilder RB, Tucker SL, Ha CS, Rodriguez MA, Hess MA, Cabanillas FF and Cox JD. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy. International Journal of Radiation Oncology, Biology and Physics 2001; 49: 17-22.
5. Kolb HJ, Losslein LK, Beisser K, Schaffer E, Holler E, Schwella N, Hochhausser E, Lehmacher W, Balk O and Thierfelder S. Dose rate and fractionation of total body irradiation in dogs: Short and long term effects. Radiotherapy and Oncology 1990; 18(Suppl. 1): 51-59.
6. Laing EJ, Fitzpatrick PJ, Binnington AG, Norris AM, Mosseri A, Rider WD, Valli VE and Bauer A. Half-body radiotherapy in the treatment of canine lymphoma. Journal of Veterinary Internal Medicine 1989; 3: 102-108.
7. Williams LE, Johnson JL, Hauck ML, Ruslander DM, Price GS and Thrall DE. Chemotherapy followed by half-body radiation therapy for canine lymphoma. Journal of Veterinary Internal Medicine 2004; 18: 703-709.
8. Gustafson NR, Lana SE, Mayer MN and LaRue SM. A preliminary assessment of whole-body radiotherapy interposed within a chemotherapy protocol for canine lymphoma. Veterinary and Comparative Oncology 2004; 2: 124-131.
9. Deeg HJ, Appelbaum FR, Weiden PL, Hackman RC, Graham TC and Storb R. Autologous marrow transplantation as consolidation therapy for canine lymphoma: Efficacy and toxicity of various regimens of total body irradiation. American Journal of Veterinary Research 1985; 46: 2016-2018.
10. Abrams-Ogg AC, Kruth SA, Carter RF, Dick JE, Valli VE, Kamel-Reid S and Dube ID. Clinical and pathological findings in dogs following supralethal total body irradiation with and without infusion of autologous long-term marrow culture cells. Canadian Journal of Veterinary Research 1993; 57: 79-88.
11. Brown EM, Ruslander DM, Azuma C, Moore AS, Bengston AE, Quesenberry PJ and Frimberger AE. A feasibility study of low-dose total body irradiation for relapsed canine lymphoma. Veterinary and Comparative Oncology 2006; 4: 75-83.
12. Owen LN. TNM Classification of Tumors in Domestic Animals. Geneva, Switzerland, World Health Organization, 1980.
13. Modiano JF, Smith R, Wojcieszyn J, Thomas JS, Rosenbaum BA, Ball C, Nicholds EA, Anthony MA and Barton CL. The use of cytochemistry, immunophenotyping, flow cytometry, and in vitro differentiation to determine the ontogeny of a canine monoblastic leukemia. Veterinary Clinical Pathology 1998; 27: 40-49.
14. Siedlecki CT, Kass PH, Jakubiak MJ, Dank G, Lyons J and Kent MS. Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma. Canadian Veterinary Journal 2006; 47: 52-59.
15. Laing EJ, Fitzpatrick PJ, Binnington AG, Norris AM, Mosseri A, Rider WD, Valli VE and Baur A. Half-body radiotherapy. Journal of Veterinary Internal Medicine 1989; 3: 96-101.
16. Vail DM. Veterinary co-operative oncology group-common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Veterinary and Comparative Oncology 2004; 2: 194-213.
17. Rice JE and Ihle SL. Effects of diet on fecal occult blood testing in healthy dogs. Canadian Journal of Veterinary Research 1994; 58: 134-137.
18. Hall EJ. Radiobiology for the Radiobiologist, 5th edn. Philadelphia, PA, Lippincott Williams and Wilkins, 2000.
19. Storb R, Raff R, Graham T, Appelbaum F, Deeg H, Schuening F, Sale G and Seidel K. Dose rate dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation. Biology of Blood and Marrow Transplant 1999; 5: 155-161.
20. Storb R, Raff RF, Appelbaum FR, Deeg HJ, Graham TC, Schuening FG, Sale G, Bryant E and Seidel K. Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine litter-mates for DLA-identical marrow grafts. Blood 1994; 83: 3384-3389.
21. Fitzpatrick PJ and Rider WD. Half-body radiotherapy. International Journal of Radiation Oncology, Biology and Physics 1976; 1: 197.
22. Northdurft W and Kreja L. Hemopoietic progenitor cells in the blood as indicators of the functional status of the bone marrow after total-body and partial-body irradiation: Experiences from studies in dogs. Stem Cells 1998; 16: 97-111.
23. Northdurft W, Baltschukat K and Fleidner TM. Hematological effects in dogs after sequential irradiation of the upper and lower part of the body with single myeloablative doses. Radiotherapy and Oncology 1989; 14: 247-259.
24. Storb R, Raff R, Graham T, Appelbaum F, Deeg H, Schuening F, Shulman H and Pepe M. Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model. International Journal of Radiation Oncology, Biology and Physics 1993; 29: 218-219.
25. Sabharwal BD, Malhotra VV, Aruna SS and Grewal RR. Comparative evaluation of bone marrow aspirate particle smears, imprints and biopsy sections. Journal of Postgraduate Medicine 1990; 36: 194-198.
26. White DC. An Atlas of Radiation Histopathology, Vol. 1. Springfield, VA, Technical Information Center, Office of Public Affairs, U.S. Energy Research and Development Administration, 1975.
27. Naylor RJ and Rudd JA. Mechanisms of chemotherapy/radiotherapy-induced emesis in animal models. Oncology 1996; 53(Suppl. 1): 8-17.
28. McCann D. Radiation poisoning: Current concepts in the acute radiation syndrome. American Journal of Clinical Medicine 2006; 3: 13-21.
29. Axiak SM, Carreras JK, Hahn KA, Endicott MM, Parshley DE and King GK. Hematologic changes associated with half-body irradiation in dogs with lymphoma. Journal of Veterinary Internal Medicine 2006; 20: 1398-1401.
30. Kiguchi K, Ishiwata I, Ishiwata C, Ishiwata E, Koshitaka Y, Iwata M, Okuda Y, Kobayashi Y, Wada Y, Ishizuka B and Ishikawa H. Establishment and characterization of human malignant lymphoma cell line derived from uterine cervix. Human Cell 2005; 18: 53-58.
31. Kanzaki T, Kubonishi I, Eguchi T, Yano S, Sonobe H, Ohyashiki JH, Ohyashiki K, Toyama K, Ohtsuki Y and Miyoshi I. Establishment of a new Hodgkin's cell line (HD-70) of B-cell origin. Cancer 1992; 69: 1034-1041.
32. Jones PW, Bogardus CR and Anderson BW. Significance of initial "performance status" in patients receiving half-body irradiation. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 1947-1950.
33. Salazar OM, Da Motta NW, Bridgman SM, Cardiges NM and Slawson RG. Fractionated half-body irradiation for pain palliation in widely metastatic cancers: Comparison with single dose. International Journal of Radiation Oncology, Biology and Physics 1996; 36: 49-60.